Evidence map›Paper›PMID 25499232›Full record

ArticleLeukemia research2015

Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.

Charnise Goodings, Rati Tripathi, Susan M Cleveland, Natalina Elliott, Yan Guo, Yu Shyr, Utpal P Davé

Open access · greenAbstract read
In one paragraph

Article in Leukemia research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Charnise GoodingsDepartments of Cancer Biology and Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Rati TripathiDepartments of Cancer Biology and Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Susan M ClevelandDepartments of Cancer Biology and Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Natalina ElliottDepartments of Cancer Biology and Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Yan GuoDepartment of Biostatistics and Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Yu ShyrDepartment of Biostatistics and Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Utpal P DavéDepartments of Cancer Biology and Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: utpal.dave@vanderbilt.edu.
Vanderbilt University Medical Center · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
Pathophysiology of Adult T-cell Leukemia/LymphomaI01BX001799 · VA · VETERANS HEALTH ADMINISTRATION · PI DAVE, UTPAL P · 2013 to 2025
–
BLRD VA I01 BX001799NCI NIH HHS P30 CA68485NCI NIH HHS T32CA009592NIDDK NIH HHS DK058404NIGMS NIH HHS R25 GM062459NIGMS NIH HHS R25GM062459
6 · The paper itself

Abstract

LIM domain only-2 (LMO2) overexpression in T cells induces leukemia but the molecular mechanism remains to be elucidated. In hematopoietic stem and progenitor cells, Lmo2 is part of a protein complex comprised of class II basic helix loop helix proteins, Tal1and Lyl1. The latter transcription factors heterodimerize with E2A proteins like E47 and Heb to bind E boxes. LMO2 and TAL1 or LYL1 cooperate to induce T-ALL in mouse models, and are concordantly expressed in human T-ALL. Furthermore, LMO2 cooperates with the loss of E2A suggesting that LMO2 functions by creating a deficiency of E2A. In this study, we tested this hypothesis in Lmo2-induced T-ALL cell lines. We transduced these lines with an E47/estrogen receptor fusion construct that could be forced to homodimerize with 4-hydroxytamoxifen. We discovered that forced homodimerization induced growth arrest in 2 of the 4 lines tested. The lines sensitive to E47 homodimerization accumulated in G1 and had reduced S phase entry. We analyzed the transcriptome of a resistant and a sensitive line to discern the E47 targets responsible for the cellular effects. Our results suggest that E47 has diverse effects in T-ALL but that functional deficiency of E47 is not a universal feature of Lmo2-induced T-ALL.

Indexed as

Protein MultimerizationAdaptor Proteins, Signal TransducingBasic Helix-Loop-Helix ProteinsCell Cycle CheckpointsCell Line, TumorCell Transformation, NeoplasticHumansLeukemia, T-CellLIM Domain ProteinsProto-Oncogene ProteinsResponse ElementsTranscription Factor 3Adaptor Proteins, Signal TransducingBasic Helix-Loop-Helix ProteinsLIM Domain ProteinsLMO2 protein, humanProto-Oncogene ProteinsTCF12 protein, humanTCF3 protein, humanTranscription Factor 3E2ALMO2T-ALLT-cell leukemia

Identifiers

PMID25499232
PMCPMC4277943
OpenAlexW2062262736

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.